An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic resistance to common breast cancer drugs—including a class of targeted ...
Key TakeawaysKidney transplant recipients who’ve never been exposed to the Epstein-Barr virus but receive organs from a donor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback